<DOC>
	<DOCNO>NCT00796224</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics ( PK ) , safety clinical response follow single dose either 30 mg/kg IR ( Immediate Release ) 60 mg/kg ER ( Extended Release ) formulation pediatric subject 6 month 6 year age inclusive .</brief_summary>
	<brief_title>Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Subjects age 6 month &lt; 12 year . Have clinical signs/symptoms acute otitis medium least one ear . Parent ( ) /legal guardian ( ) provide write informed consent . Clinical significant disease . Recent use investigational drug , prescription nonprescription drug .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>azithromycin , pharmacokinetics , pediatrics</keyword>
</DOC>